市场调查报告书
商品编码
1464848
心肺体外迴圈设备市场:按产品、应用和最终用户划分 - 全球预测 2024-2030Cardiopulmonary Bypass Equipment Market by Product (Autotransfusion Systems, Heart-Lung Machines, Oxygenators), Application (Cardiovascular, Hemodialysis, Respiratory), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2023年心肺体外迴圈设备市场规模预计为3.0691亿美元,预计2024年将达到3.1992亿美元,2030年将达到4.1451亿美元,复合年增长率为4.38%。
心肺体外迴圈机是心肺体外迴圈(CPB) 手术的核心,其中包括复杂的组件,旨在在心血管手术期间暂时接管心臟和肺部的功能。该装置包括心肺体外迴圈装置、血液输送管、用氧气浓缩血液并去除二氧化碳的氧合器,以及各种其他组件,例如热交换器、过滤器和储液器。其主要目的是维持循环和呼吸稳定性,使外科医生能够在无血区域对静止的心臟进行手术,并提高手术的可视性和有效性。心肺体外迴圈机透过精确控制血流、温度和气体交换,在复杂心血管手术的成功中发挥着至关重要的作用。由于需要手术干预的心臟病发病率上升,老年人口不断增长,这有助于市场扩张。然而,体外循环设备和手术的高成本可能会限制市场成长,特别是在医疗系统较不先进的地区。然而,微创手术的进步以及体外循环过程中用于监测和预测分析的人工智慧的整合预计将代表该领域的重大成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 30691万美元 |
预测年份 [2024] | 31992万美元 |
预测年份 [2030] | 41451万美元 |
复合年增长率(%) | 4.38% |
产品:快速增加氧气输送装置的使用,以提高整体手术的安全性和有效性
自动输血系统旨在在手术过程中和手术后收集、处理和回输患者血液。这项技术在预计大量失血的手术中至关重要,可以减少对血液供应输血的依赖,并降低血液感染和反应的风险。自动输血系统已经发展到最大限度地减少患者接触捐血的机会,解决了主要的安全问题。心肺体外迴圈机在心血管手术中至关重要,它透过给患者体外的血液氧气和循环来支持循环和呼吸。这台机器对于需要暂时停止心臟跳动的手术至关重要,例如冠状动脉绕道手术手术 (CABG)。心肺体外迴圈设备不断进行创新,以改善控制和患者治疗结果,特别是透过人工智慧技术的整合。氧合器在心肺体外迴圈机中发挥重要作用,在心血管手术期间接管肺部的气体交换功能。即使患者的肺部不使用,也必须确保维持血液氧合。氧气吸入器具有更好的气体交换能力和最小的併发症,提高了整个手术的安全性和有效性。
最终用户:透析中心心肺体外迴圈机的高利用率
在透析中心,治疗需要暂时血液滤过,简单、有效率、可靠的设备是首要任务。这里需要的是支援肾臟透析独特要求的设备,通常具有便于轻鬆监测和管理液体平衡和电解质水平的整合功能。医院构成了心肺体外迴圈机最广泛的消费者基础,因为它们执行各种需要血液循环支持的外科手术,例如心血管手术。医院需要多功能、大容量的设备,能够处理各种复杂程度不同的手术。它还需要与医院资讯系统相容,以实现无缝整合。包括心臟护理在内的专科诊所是心肺体外迴圈设备的新兴市场。这些诊所通常进行非紧急手术和治疗,需要紧凑、易于使用且具有成本效益的设备。人们关注的是满足特定手术需求和患者群体的设备。
区域洞察
在技术进步和该地区心血管手术增加的推动下,美国心肺体外迴圈设备市场呈现强劲成长。美国因其先进的医疗基础设施、高昂的医疗成本以及主要市场参与者的强大影响力而在该市场处于领先地位。此外,人们对心血管疾病及其治疗方法的认识不断提高,进一步推动了市场的成长。欧洲是心肺体外迴圈设备的重要市场,受到成熟的医疗保健系统和人口中心血管疾病盛行率不断上升的推动。欧洲国家正在大力投资旁路装置创新的研发,以产生更好的结果并减少手术时间。中东和非洲对心肺体外迴圈机的需求正在成长,儘管成长速度慢于其他地区。在中东和非洲,市场成长主要由医疗设施的逐步改善和医疗服务覆盖范围的增加所推动。该地区正在进行国际合作和投资,以加强医疗基础设施,特别是在海湾地区。亚太地区正在成为心肺体外迴圈设备的动态成长市场。医疗成本上升、心血管疾病盛行率上升以及医疗基础设施改善等因素正在推动市场成长,尤其是在中国和印度等国家。此外,政府对医疗改革的日益关注和积极主动的倡议正在改善该地区的市场前景。
FPNV定位矩阵
FPNV 定位矩阵对于评估心肺体外迴圈设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对心肺体外迴圈设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.心肺体外迴圈设备市场规模及预测为何?
2.在心肺体外迴圈设备市场预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.心肺体外迴圈设备市场的技术趋势与法规结构是什么?
4.心肺体外迴圈设备市场主要供应商的市场占有率是多少?
5.进入心肺体外迴圈设备市场的合适型态和策略手段是什么?
[191 Pages Report] The Cardiopulmonary Bypass Equipment Market size was estimated at USD 306.91 million in 2023 and expected to reach USD 319.92 million in 2024, at a CAGR 4.38% to reach USD 414.51 million by 2030.
Cardiopulmonary bypass equipment, central to cardiopulmonary bypass (CPB) procedures, encompasses a sophisticated assembly designed to temporarily assume the functions of the heart and lungs during cardiac surgery. This arrangement includes a heart-lung machine, tubing for blood transport, an oxygenator to enrich the blood with oxygen and remove carbon dioxide, and various other components such as heat exchangers, filters, and reservoirs. Its primary aim is to maintain circulatory and respiratory stability, enabling surgeons to operate on a still heart in a bloodless field, thus improving surgical visibility and efficacy. Cardiopulmonary bypass equipment plays a pivotal role in the successful outcome of complex cardiac surgeries by precisely controlling blood flow, temperature, and gas exchange. An increase in the geriatric population with rising incidence of cardiac conditions necessitating surgical intervention contributes to market expansion. However, the high cost of CPB devices and surgery can limit market growth, especially in regions with less advanced healthcare systems. Nevertheless, advancements in minimally invasive surgeries and the integration of artificial intelligence for monitoring and predictive analysis during CPB procedures are expected to be significant growth opportunities within the sector.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 306.91 million |
Estimated Year [2024] | USD 319.92 million |
Forecast Year [2030] | USD 414.51 million |
CAGR (%) | 4.38% |
Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
Autotransfusion systems are designed for collecting, processing, and reinfusion of a patient's blood during and after a surgical procedure. This technique is essential in surgeries where significant blood loss is anticipated, reducing the dependency on donor blood transfusions and thus lowering the risks of bloodborne infections and reactions. Autotransfusion systems have evolved to minimize patient exposure to donor blood, addressing major safety concerns. Heart-lung machines are critical for cardiac surgeries, providing circulatory and respiratory support by oxygenating and circulating blood outside the patient's body. This machine is indispensable for procedures requiring the temporary cessation of the heart, such as coronary artery bypass grafting (CABG). Heart-lung machines continue to see innovations to enhance control and patient outcomes, particularly with the integration of AI technologies. Oxygenators play a crucial role in cardiopulmonary bypass equipment, taking over the function of gas exchange from the lungs during cardiac surgeries. They are essential in ensuring the blood remains oxygenated while the patient's lungs are not in use. Oxygenators are being developed with better gas exchange capabilities and minimized complications, enhancing overall procedure safety and effectiveness.
End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
Dialysis centers primarily focus on treatments that require temporary blood filtration, making simple, efficient, and reliable machines a priority. The need here is for equipment that supports the specific requirements of renal dialysis, often integrating features that facilitate easy monitoring and management of fluid balance and electrolyte levels. Hospitals form the most extensive consumer base for cardiopulmonary bypass equipment, given their broad range of surgical procedures that require blood circulation support, such as cardiac surgeries. Hospitals need versatile, high-capacity machines capable of supporting various methods with different complexity levels. Equipment should also be compatible with hospital information systems for seamless integration. Specialty clinics, including those focusing on cardiac care, represent an emerging market for cardiopulmonary bypass equipment. These clinics generally deal with non-emergency surgeries and treatments, necessitating compact, easy-to-use, and cost-effective equipment. The focus is on devices catering to specific surgical needs or patient populations.
Regional Insights
The American market for cardiopulmonary bypass equipment is showing robust growth, driven by technological advancements and increasing cardiac surgeries in the region. The United States leads this market due to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key market players. Moreover, increasing awareness about cardiovascular diseases and their treatment options further fuels market growth. Europe is a significant market for cardiopulmonary bypass equipment, supported by its well-established healthcare system and the growing prevalence of cardiovascular diseases among its population. Countries in Europe are investing largely in research and development to innovate bypass machines that offer better outcomes and reduce surgery durations. Middle East and Africa exhibit a growing demand for cardiopulmonary bypass equipment, although at a slower pace than other areas. In the Middle East and Africa, the market growth is primarily driven by the gradual enhancement of healthcare facilities and increasing access to healthcare. The region sees international collaborations and investments, particularly in the Gulf countries, to bolster healthcare infrastructure. The APAC region is emerging as a dynamically growing market for cardiopulmonary bypass equipment. Factors including increasing healthcare expenditure, the growing prevalence of cardiovascular diseases, and improving healthcare infrastructure, particularly in countries like China and India, propel the market growth. Additionally, the rising focus on healthcare reforms and favorable government initiatives are enhancing market prospects in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cardiopulmonary Bypass Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiopulmonary Bypass Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cardiopulmonary Bypass Equipment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiopulmonary Bypass Equipment Market?
3. What are the technology trends and regulatory frameworks in the Cardiopulmonary Bypass Equipment Market?
4. What is the market share of the leading vendors in the Cardiopulmonary Bypass Equipment Market?
5. Which modes and strategic moves are suitable for entering the Cardiopulmonary Bypass Equipment Market?